Home › Stocks › CLDI

Calidi Biotherapeutics, Inc. (CLDI): insider buying, hedge funds & Congress trades

Calidi Biotherapeutics, Inc. (CLDI): 4 insider purchases in the last two years.

Insider buying

FiledInsiderSharesPriceValueType
Aug 25, 2025Schoeneck James A
Director
75,000$2.00$150.0Kno history
Aug 25, 2025Poma Eric E
Director, Officer
25,000$2.00$50.0Kno history
Aug 25, 2025Leftwich Scott
Director
125,000$2.00$250.0Kno history
Aug 25, 2025Jackson Andrew C.
Officer
2,500$2.00$5.0Kno history

Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.

Get alerts for CLDI

Free account. Know when insiders, famous funds or Congress trade it.

Start free